↓ Skip to main content

JIMD Reports, Volume 29

Overview of attention for book
Cover of 'JIMD Reports, Volume 29'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 297 Spectrum of Mutations in 60 Saudi Patients with Mut Methylmalonic Acidemia
  3. Altmetric Badge
    Chapter 336 LC-MS/MS Analysis of Cerebrospinal Fluid Metabolites in the Pterin Biosynthetic Pathway
  4. Altmetric Badge
    Chapter 372 Erratum to: LC-MS/MS Analysis of Cerebrospinal Fluid Metabolites in the Pterin Biosynthetic Pathway
  5. Altmetric Badge
    Chapter 493 CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome.
  6. Altmetric Badge
    Chapter 495 Continual Low-Dose Infusion of Sulfamidase Is Superior to Intermittent High-Dose Delivery in Ameliorating Neuropathology in the MPS IIIA Mouse Brain.
  7. Altmetric Badge
    Chapter 507 A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts.
  8. Altmetric Badge
    Chapter 508 Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age
  9. Altmetric Badge
    Chapter 509 Renal Involvement in a French Paediatric Cohort of Patients with Lysinuric Protein Intolerance
  10. Altmetric Badge
    Chapter 513 Correlation Between Flexible Fiberoptic Laryngoscopic and Polysomnographic Findings in Patients with Mucopolysaccharidosis Type VI.
  11. Altmetric Badge
    Chapter 517 A Highly Diverse Portrait: Heterogeneity of Neuropsychological Profiles in cblC Defect.
  12. Altmetric Badge
    Chapter 519 Heterozygous Monocarboxylate Transporter 1 (MCT1, SLC16A1 ) Deficiency as a Cause of Recurrent Ketoacidosis
  13. Altmetric Badge
    Chapter 520 The Lactose and Galactose Content of Cheese Suitable for Galactosaemia: New Analysis
  14. Altmetric Badge
    Chapter 521 Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation.
  15. Altmetric Badge
    Chapter 525 Atypical Clinical Presentations of TAZ Mutations: An Underdiagnosed Cause of Growth Retardation?
  16. Altmetric Badge
    Chapter 526 Abnormal Glycosylation Profile and High Alpha-Fetoprotein in a Patient with Twinkle Variants. - PubMed - NCBI
  17. Altmetric Badge
    Chapter 529 Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrosp... - PubMed - NCBI
  18. Altmetric Badge
    Chapter 574 Erratum to: Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency
Attention for Chapter 508: Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age
Chapter number 508
Book title
JIMD Reports, Volume 29
Published in
JIMD Reports, January 2015
DOI 10.1007/8904_2015_508
Pubmed ID
Book ISBNs
978-3-66-253277-5, 978-3-66-253278-2
Authors

P. Burgard, E. Mönch, J. Zschocke, U. Wendel, U. Langenbeck, On behalf of the German Collaborative Study of Phenylketonuria (PKU)/Hyperphenylalaninaemia (HPA), Burgard, P., Mönch, E., Zschocke, J., Wendel, U., Langenbeck, U.

Abstract

As part of the German Collaborative Study on Phenylketonuria (PKU)/Hyperphenylalaninaemia (HPA) Study Protocol, a Blaskovics protein loading test (180 mg phenylalanine (phe) protein equivalent per kg body weight and day for 72 h) had been applied to 145 children at the age of 6 months. For investigating possible age-related changes of metabolic phenotype, 51 of them received a 2nd loading test at 5 years of age. Besides the analysis of blood phe levels, acidic phe transamination metabolites were quantified in urine. Compared to the 6-month data, the mean blood phe level 72 h after start of loading (Phe72) was found to be decreased by 7% (P = 0.06), whereas the mean urinary excretion (per 1.73 m(2) body surface and day) of 2-hydroxyphenylacetic acid was increased 1.9-fold (P < 0.01). Corresponding with these analytical data, the kinetic model constant k out of metabolic plus renal phe disposal was found increased 1.3-fold in mean (P < 0.01).In 3 of the 51 patients, Phe72 was very high at 6 months while in the medium range at 5 years, suggesting that catabolic states may mimic a more severe metabolic defect.The blood phe level response of mild PKU (type II) was assigned identically at both ages in 7/9 patients. Diverging results were (i) response type III (mild hyperphenylalaninaemia) at 6 months and type II at 5 years and (ii) type II at 6 months and type III at age 5. Renal elimination of OHPAA and phe tolerance increase significantly between the age of 6 months and 5 years, suggesting that, at least in childhood, formation and/or renal disposal of phe transamination metabolites may be major distal determinants of phe tolerance.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 40%
Professor > Associate Professor 1 20%
Other 1 20%
Unknown 1 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 40%
Pharmacology, Toxicology and Pharmaceutical Science 1 20%
Medicine and Dentistry 1 20%
Unknown 1 20%